Picture of Ayala Pharmaceuticals logo

ADXS Ayala Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Advaxis Reports Q1 Financial Results And Provides A Business Update

March 16 (Reuters) - Advaxis Inc  ADXS.O :
    * ADVAXIS REPORTS FIRST QUARTER ENDED JANUARY 31, 2021
FINANCIAL
RESULTS AND PROVIDES A BUSINESS UPDATE
    * ADVAXIS INC - AS OF JANUARY 31, 2021, COMPANY HAD
APPROXIMATELY
$33.3 MILLION IN CASH AND CASH EQUIVALENTS
    * ADVAXIS INC - BELIEVES HAS SUFFICIENT CAPITAL TO FUND ITS
OBLIGATIONS, AS THEY BECOME DUE, IN ORDINARY COURSE OF BUSINESS
UNTIL MAY 2022
    * ADVAXIS INC - QTRLY LOSS PER SHARE $0.05

Source text for Eikon:  ID:nGNX4Lc5gK 
Further company coverage:  ADXS.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Ayala Pharmaceuticals

See all news